Business Context and Reporting Period
This Form 8-K filing by Aikido Pharma Inc. (trading symbol: AIKI) reports events occurring on June 7, 2022. The registrant is incorporated in Delaware and lists its common stock on The Nasdaq Capital Market. The filing addresses corporate governance changes and a significant capital structure adjustment.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate actions rather than financial performance metrics.
Material Changes
- Reverse Stock Split: The Company effected a 17-for-1 reverse stock split effective June 7, 2022. This reduced the outstanding common stock from approximately 89,294,446 shares to approximately 5,252,555 shares. The par value remained $0.0001 per share.
- Board Appointment: Soo Yu was appointed as a member of the Board of Directors on June 7, 2022. Ms. Yu is the wife of existing board member Kyle Wool and serves as President of Revere Securities, a firm previously utilized by the Company for investment management.
- Trading Details: Post-split shares began trading on June 7, 2022, under a new CUSIP number (0088753043). Fractional shares were rounded down to the nearest whole share.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or management commentary regarding future performance. No material risks, contingencies, or unusual items were disclosed in this specific report. The Company confirmed there are no reportable related party transactions involving the new director under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the adjusted share count and new CUSIP number (0088753043) in brokerage accounts following the 17-for-1 split.
- Confirm the absence of fractional share payments, as the Company rounded down fractional shares to the nearest whole share.
- Review the biographical background of new director Soo Yu, specifically her relationship to existing board member Kyle Wool and her role at Revere Securities.
- Check subsequent filings for any financial impact or strategic rationale related to the reverse stock split.